Políticas públicas no enfrentamento às drogas no Brasil: análise do Sistema Nacional de Políticas Públicas Sobre Drogas.

Abstract

This dissertation aims to analyze, in the light of historical neo-institutionalism, the policies to confrontation drugs in Brazil, specifically, the National System of Public Policies on Drugs (SISNAD). Materialized from the implementation of Law n. 11.343/2006, SISNAD aims to articulate, integrate, organize and coordinate activities, from a double perspective: prevention and repression. Therefore, the problem posed at work is to know: what is the path taken by the current public policy to combat drugs in Brazil (SISNAD)? The justification for choosing the present subject of study is due to the author's connection with the subject, which brings together different areas, such as Criminal Law/Criminology (under the prism of Toxicology in Legal Medicine) and Political Science, fields of study of the researcher in graduation and postgraduation. In this sense, it sought to link these research experiences to the theme of Public Policies, a sub-area of Political Science. The geographic space contemplated is Brazil and the federal legislation related to drugs. There was a concern to establish a historical overview, which dates back to our imperial era, however, the cut time punctuates the elaboration, publication and execution of the 2006 Antidrug Law, object of this study. The theoretical framework suggested emphasis on the legislation and its amendments in 2019. Data were collected, based on official institutional databases and Public Policies and institutions were highlighted, with emphasis on the main findings, translated into the implementation of SISNAD, as a model of Public Policy Restorative, in the area of Public Security and guarantee of protection of citizens' rights, configuring institutional innovation. Therefore, the methodology adopted in the dissertation is descriptive, starting from an analysis of the situation of drug policy in Brazil, based on the use of bibliographic and documental methods, both in the literature and in official data on federal legislation related to drugs.